162 related articles for article (PubMed ID: 34659225)
1. Proton Pump Inhibitors Increase the Risk of Autoimmune Diseases: A Nationwide Cohort Study.
Lin SH; Chang YS; Lin TM; Hu LF; Hou TY; Hsu HC; Shen YC; Kuo PI; Chen WS; Lin YC; Chen JH; Chang CC
Front Immunol; 2021; 12():736036. PubMed ID: 34659225
[TBL] [Abstract][Full Text] [Related]
2. Risk of incident autoimmune diseases in patients with thymectomy.
Lin TM; Chang YS; Hou TY; Hsu HC; Lin SH; Chen WS; Kuo PI; Lin YC; Chen JH; Chang CC
Ann Clin Transl Neurol; 2020 Jul; 7(7):1072-1082. PubMed ID: 32478484
[TBL] [Abstract][Full Text] [Related]
3. Incidence of autoimmune diseases in patients with scabies: a nationwide population-based study in Taiwan.
Liu JM; Chiu FH; Lin CY; Chang FW; Hsu RJ
Rheumatol Int; 2017 Jul; 37(7):1125-1134. PubMed ID: 28421357
[TBL] [Abstract][Full Text] [Related]
4. Risk of systemic autoimmune diseases in gastric disease patients with proton pump inhibitor use: a nationwide cohort study in Taiwan.
Chen HY; Lin JJ; Yang B; Lin MC
Clin Rheumatol; 2020 Sep; 39(9):2773-2780. PubMed ID: 32152918
[TBL] [Abstract][Full Text] [Related]
5. Androgen deprivation therapy for prostate cancer and the risk of autoimmune diseases.
Liu JM; Yu CP; Chuang HC; Wu CT; Hsu RJ
Prostate Cancer Prostatic Dis; 2019 Sep; 22(3):475-482. PubMed ID: 30692587
[TBL] [Abstract][Full Text] [Related]
6. Proton pump inhibitor use and the risk of osteoporosis and fracture in stroke patients: a population-based cohort study.
Lin SM; Yang SH; Liang CC; Huang HK
Osteoporos Int; 2018 Jan; 29(1):153-162. PubMed ID: 29032384
[TBL] [Abstract][Full Text] [Related]
7. Increased risk of autoimmune diseases in dengue patients: A population-based cohort study.
Li HM; Huang YK; Su YC; Kao CH
J Infect; 2018 Sep; 77(3):212-219. PubMed ID: 29746944
[TBL] [Abstract][Full Text] [Related]
8. Proton Pump Inhibitors and Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B or C.
Kao WY; Su CW; Chia-Hui Tan E; Lee PC; Chen PH; Tang JH; Huang YH; Huo TI; Chang CC; Hou MC; Lin HC; Wu JC
Hepatology; 2019 Mar; 69(3):1151-1164. PubMed ID: 30175498
[TBL] [Abstract][Full Text] [Related]
9. Risk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan.
Tai SY; Chien CY; Wu DC; Lin KD; Ho BL; Chang YH; Chang YP
PLoS One; 2017; 12(2):e0171006. PubMed ID: 28199356
[TBL] [Abstract][Full Text] [Related]
10. Incidence of autoimmune diseases in a nationwide HIV/AIDS patient cohort in Taiwan, 2000-2012.
Yen YF; Chuang PH; Jen IA; Chen M; Lan YC; Liu YL; Lee Y; Chen YH; Chen YA
Ann Rheum Dis; 2017 Apr; 76(4):661-665. PubMed ID: 27590658
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune diseases associated with non-Hodgkin lymphoma: a nationwide cohort study.
Fallah M; Liu X; Ji J; Försti A; Sundquist K; Hemminki K
Ann Oncol; 2014 Oct; 25(10):2025-2030. PubMed ID: 25081899
[TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitors use and the risk of fatty liver disease: A nationwide cohort study.
Pyo JH; Kim TJ; Lee H; Choi SC; Cho SJ; Choi YH; Min YW; Min BH; Lee JH; Kang M; Lee YC; Kim JJ
J Gastroenterol Hepatol; 2021 May; 36(5):1235-1243. PubMed ID: 32886822
[TBL] [Abstract][Full Text] [Related]
13. Proton pump inhibitor use and the risk for Parkinson's disease: A nationwide population-based study in Taiwan.
Chen HL; Lei WY; Wang JH; Bair MJ; Chen CL
Medicine (Baltimore); 2023 May; 102(19):e33711. PubMed ID: 37171333
[TBL] [Abstract][Full Text] [Related]
14. Proton pump inhibitor use represents an independent risk factor for myocardial infarction.
Shih CJ; Chen YT; Ou SM; Li SY; Chen TJ; Wang SJ
Int J Cardiol; 2014 Nov; 177(1):292-7. PubMed ID: 25499395
[TBL] [Abstract][Full Text] [Related]
15. Risk of Autoimmune Diseases Following Optic Neuritis: A Nationwide Population-Based Cohort Study.
Ma KS; Lee CM; Chen PH; Yang Y; Dong YW; Wang YH; Wei JC; Zheng WJ
Front Med (Lausanne); 2022; 9():903608. PubMed ID: 35770018
[TBL] [Abstract][Full Text] [Related]
16. Association Between Severity of Leptospirosis and Subsequent Major Autoimmune Diseases: A Nationwide Observational Cohort Study.
Chen CC; Hung YM; Chiu LT; Chou MC; Chang R; Wei JC
Front Immunol; 2021; 12():721752. PubMed ID: 34566978
[TBL] [Abstract][Full Text] [Related]
17. Effects of Anti-Helicobacter pylori Therapy on Incidence of Autoimmune Diseases, Including Inflammatory Bowel Diseases.
Lin KD; Chiu GF; Waljee AK; Owyang SY; El-Zaatari M; Bishu S; Grasberger H; Zhang M; Wu DC; Kao JY
Clin Gastroenterol Hepatol; 2019 Sep; 17(10):1991-1999. PubMed ID: 30580094
[TBL] [Abstract][Full Text] [Related]
18. Proton Pump Inhibitor Use and Risk of Serious Infections in Young Children.
Lassalle M; Zureik M; Dray-Spira R
JAMA Pediatr; 2023 Oct; 177(10):1028-1038. PubMed ID: 37578761
[TBL] [Abstract][Full Text] [Related]
19. Proton Pump Inhibitors Are Associated with Increased Risk of Psoriasis: A Nationwide Nested Case-Control Study.
Li CY; Dai YX; Chang YT; Bai YM; Tsai SJ; Chen TJ; Chen MH
Dermatology; 2021; 237(6):884-890. PubMed ID: 34474411
[TBL] [Abstract][Full Text] [Related]
20. Association of Proton Pump Inhibitors Usage with Risk of Pneumonia in Dementia Patients.
Ho SW; Teng YH; Yang SF; Yeh HW; Wang YH; Chou MC; Yeh CB
J Am Geriatr Soc; 2017 Jul; 65(7):1441-1447. PubMed ID: 28321840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
